×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Association between estrogen and androgen receptor genes and prostate cancer risk.
18952763
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
19147544
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.
18977589
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
18776922
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
GeneticVariation
LHGDN
Polymorphisms in genes regulating androgen activity among prostate cancer low-risk Inuit men and high-risk Scandinavians.
17376218
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
GeneticVariation
LHGDN
Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice.
17906287
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.
18451177
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells.
18602367
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
18181049
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion.
18266956
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
18780293
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor.
18479901
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers.
18372911
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study.
18217192
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells.
18178153
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Role of an androgen receptor gene polymorphism in development of hormone refractory prostate cancer in Indian population.
17696745
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Cyclin D3 action in androgen receptor regulation and prostate cancer.
18084330
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful?
18516299
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.
18324648
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer.
18511414
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
LHGDN
Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells.
18726991
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
One common change in prostate tumors is overexpression of the AR , which has been shown to lead to androgen-independent growth of prostate cancer cells.
18469090
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
A role for the androgen-receptor in clinically localized and advanced prostate cancer.
18471792
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
18413735
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
AlteredExpression
LHGDN
Androgen receptor regulates CD168 expression and signaling in prostate cancer.
18174258
2008